Bradley David Gelfand

University of Virginia

NIH Rank #2817
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.9M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#2,817
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.9M across 5 grants · National rank #2817.

Top grants by award amount

Bradley David Gelfand's NIH grant portfolio, ranked by award amount.

  • 5R01HL164592-02R01
    Mechanistic basis of sexual dimorphism in antigen-independent IgG1 angiogenesis regulation
    $651.1K
    award amount
  • 5R01AG082748-02R01
    Cytosolic SINE retrotransposable element cDNA and mitochondrial DNA in aging retina
    $631.8K
    award amount
  • 5R01AG078892-03R01
    Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease
    $620.8K
    award amount
  • 5R01EY032512-04R01
    DICER1 deficiency in aberrant chorioretinal neovascularization
    $510.4K
    award amount
  • 5R01EY031039-05R01
    Nlrp3 inflammasome activation in early diabetic retinopathy
    $472.8K
    award amount

Affiliation

Institutions that have administered grants for Bradley David Gelfand.

Affiliated with University of Virginia (VA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Virginia
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2817
  6. 2024
    Entered Top 25% Nationally
    Ranked #2817